The global 3D printed drugs market was estimated at USD 214.3 million in 2017, and is predicted to touch USD 295.5 million by 2025, while increasing at a CAGR of 4.2% till 2025.

Figure 1: Global 3D Printed Drugs Market Revenue, 2018–2025 (USD Million)

Source: GMI Research

Introduction of the 3D Printed Drugs Market Report

In the medical industry, 3d printing technology is increasingly used to create custom-made prosthetics, implants, and other medical devices. 3d printing technology is even being used to develop 3d bioprinted organs. This technology in the pharmaceutical industry has given pharmacists and medical engineers the ability to customize drugs by modifying the design straight to its CAD file. It also enables the healthcare provider to print medicines on-demand rather than mass production.

To have an edge over the competition by knowing the market dynamics and current trends of “3D Printed Drugs Market,” request for Sample Report here

Market Dynamic

Key Drivers and Emerging Trends

The global 3D printed drugs market is projected to experience an increase in demand during the forecast period. The strong demand for rapid soluble drugs, along with the rising rate of the elderly population and the growing adoption of personalized drugs, are the major factors that are contributing to the growth of the market during the forecast period. In addition to this, the high adoption rate of 3d printing technology and the increasing production of combination medicine is further opening new doors for the growth of the market. The rising growth in the R&D activities related to 3D printing has surged the implementation of 3D printing technology to create personalized drug therapies.

3D printing technology provides numerous exceptional advantages, such as allows a personalized medicine system with automated control over drug dose and suitability for both low and high drug concentrations, which enables drug companies to attain better efficacy and adherence of drugs. The growing prevalence of dysphagia is encouraging individuals to opt for 3d printed drugs over the next few years. Furthermore, the rising usage of 3D printing techniques in the medical & healthcare sectors is further driving the market growth.

Figure 2: Global 3D Printed Drugs Market Revenue, by Region, 2017

Source: GMI Research

Restraint in the 3D Printed Drugs Market

On the other edge of the spectrum, the negative impact of these drugs and the lack of government regulations for 3D printed products are the two major factors that are hampering the growth of the global 3D printed drugs market over the coming years.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Technique Type – Segment Analysis

Based on the Technique Type, the fused deposition modeling segment is predicted to grow at a higher CAGR during the forecast period. This is mainly due to continuous innovations and technological advancement in the field of pharmaceutical drugs. On the other hand, the inkjet printer segment is expected to lead the market during the forecast period. The increasing adoption of this type of technology among patients owing to the numerous benefits offered by it, such as produces 3D Drugs tablets at a constant rate and other technologically advanced properties, is one of the major factors that is boosting the segment growth.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis:

Based on the region, Asia-pacific is anticipated to lead the global 3D printed drugs market during the forecast period. The continuous growth in the pharmaceutical sector in this region due to the increasing GDP is a significant factor that is responsible for the market growth in this region. In addition to this, the increasing adoption of advanced healthcare techniques by the end-users is further energizing the growth of the market. On the other edge, North America is witnessing faster CAGR in the market, attributed to the accelerating number of chronic disorders, presence of advanced domestic healthcare infrastructure, and the accelerating adoption of technological advancements in 3D printing.

Top Market Players

Various notable players operating in the market include Aprecia Pharmaceuticals LLC, GlaxoSmithKline Plc., FabRx Ltd., Hewlett Packard Caribe, Merck KGaA, Cycle Pharmaceuticals, and Tvasta, among others. 

Key Developments:

• • In 2020, Aprecia Pharmaceuticals LLC, entered into a partnership with Purdue University’s College of Pharmacy, to bring advancement in technologies and science of 3D pharmaceutical printing. Through this partnership, the companies will focus on developing future 3D printed pharmaceutical equipment and medications.
  • In 2020, Merck KGaA entered into a cooperation agreement with Additive Manufacturing Customized Machines (AMCM) to develop a prototype printer, which is projected to be completed towards the end of 2020.
  • In 2018, Cycle Pharmaceuticals signed a partnership with US-based Aprecia Pharmaceuticals for the development and commercialization of drugs for rare diseases using 3D printed technology. This partnership helped in delivering quality-of-life improvements over existing approved orphan drugs.

Segments covered in the Report:

The global 3D Printed Drugs market has been segmented on the basis of Technique Type, and key regions. Based on Technique Type, the market is segmented into Infant, Booster, Combination and Convertible. 

For detailed scope of the “3D Printed Drugs Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global 3D Printed Drugs market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in 3D Printed Drugs market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global 3D Printed Drugs market?
  • Which Technique Type generated maximum revenues in 2019 and identify the most promising Technique Type during the forecast period?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Report Coverage	Details
Market Base Year	2019
Market Forecast Period	2020-2027
Market Revenues Currency	USD Million
Base Year & Forecast Units	Revenues (USD Million)
Market Segment	By Technique Type, By Region
Regional Coverage	Asia Pacific, Europe, North America, and RoW
Companies Profiled	Aprecia Pharmaceuticals LLC, GlaxoSmithKline Plc., FabRx Ltd., Hewlett Packard Caribe, Merck KGaA, Cycle Pharmaceuticals, and Tvasta, among others; a total of 7 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Market Segmentation

Global 3D Printed Drugs Market by Technique Type

• • Fused Deposition Modelling
  • Inkjet Printing Infant
  • Selective Laser Sintering
  • Stereolithography
  • Others

Global 3D Printed Drugs Market by Region

• • North America 3D Printed Drug Market (Option 1: As a part of the free 25% customization)
    • North America Market by Technique Type
    • US Market All-Up
    • Canada Market All-Up
  • Europe 3D Printed Drug Market (Option 2: As a part of the free 25% customization)
    • Europe Market by Technique Type
    • UK Market All-Up
    • Germany Market All-Up
    • France Market All-Up
    • Spain Market All-Up
    • Rest of Europe Market All-Up
  • Asia-Pacific 3D Printed Drug Market (Option 3: As a part of the free 25% customization)
    • Asia-Pacific Market by Technique Type
    • China Market All-Up
    • India Market All-Up
    • Japan Market All-Up
    • Rest of APAC Market All-Up
  • RoW 3D Printed Drug Market (Option 4: As a part of the free 25% customization)
    • RoW Market by Technique Type
    • Brazil Market All-Up
    • South Africa Market All-Up
    • Saudi Arabia Market All-Up
    • UAE Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Market All-Up

Major Players Operating in the 3D Printed Drug(Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Aprecia Pharmaceuticals LLC
  • GlaxoSmithKline Plc.
  • FabRx Ltd.
  • Hewlett Packard Caribe
  • Merck KGaA
  • Cycle Pharmaceuticals
  • Tvasta